Emerging multidrug-resistant Candida auris: information on infection control practices
The following information was sent to PICNet's Community of Practice on July 14, 2016; you can also download the following information as a PDF. PICNet has also prepared a Q&A that you can view in our previous news post or as a PDF. Background The US Centers for Disease Control and Prevention and the Public Health Agency of Canada have recently raised an alert to an emerging multidrug-resistant (MDR) yeast, Candida auris (C....
Candida auris Q&A
PICNet has prepared the following Q&A to assist you with questions from staff or patients. You can also download this information as a PDF. View our subsequent news post for infection control and laboratory testing information. What is Candida auris? Is it a new type of infection? Candida auris is a type of Candida yeast. Candida yeasts normally live on the skin and mucous membranes but can cause yeast infections. C. auris was first identified in...
Emerging global HAI-AMR issue: Candida auris
PHAC communication PHAC has recently learned of a public health alert from US CDC in relation to the global emergence of invasive infections caused by the multidrug-resistant yeast organism, Candida auris. While C. auris is not common, it can cause invasive infections associated with high mortality and has also been known to cause outbreaks in health-care facilities. Information available to date indicates that cases of C. auris have occurred in at least nine...